Veronica Armato

Mrs. Veronica Armato


Research Focus & Metrics

Academic Career Length

1Year (2026-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
24 April 2026 in Journal of Clinical Medicine
Verified
Journal Article
Open access
PDF file
VAVeronica Armato
Veronica Armato
MSMaria Elena Susi
Maria Elena Susi
Riccardo PicassoRiccardo Picasso
Riccardo Picasso
MMMarta Macciò
Marta Macciò
Federico PistoiaFederico Pistoia
Federico Pistoia
Alberto Stefano TagliaficoAlberto Stefano Tagliafico
Alberto Stefano Tagliafico
Background: This study aims to systematically review the current literature on the application of radiomic features and artificial intelligence (AI) in the diagnosis and prognosis of common peripheral nerve-related conditions, including carpal tunnel syndrome (CTS), chronic inflammatory demyelinating polyneuropathy (CIDP), polyneuropathy, organomegaly, endocrinopathy, monoclonal gammopathy and skin abnormalities (POEMS) syndrome, and in distinguishing between benign and malignant tumors. Methods: A comprehensive literature search was conducted in PubMed and Google Scholar for studies published between January 2019 and September 2025. Inclusion criteria comprised studies that used radiomics or AI-based radiomics approaches with diagnostic or prognostic purposes in peripheral nerve disorders. Results: A total of 40 studies were identified, of which 17 met the inclusion criteria. Among these, 9 studies employed magnetic resonance imaging (MRI), including one combined with PET/CT, while 8 used ultrasound (US). Most studies were retrospective and limited by small sample sizes, lack of external validation, and predominance of single-center designs. Conclusions: Since a seminal study published in 2019, there has been increasing evidence supporting the role of radiomics and AI in improving the diagnosis and prognosis of peripheral nerve disorders, particularly using MRI and US. However, significant challenges remain, including variability in imaging data, segmentation complexity, and limited availability of validated datasets. Future advancements in imaging technologies and multidisciplinary collaboration are essential to enhance clinical applicability.